Sector benchmark
Where does a company stand against its sector? Every ratio over five fiscal years, with its place among its peers and what that means, ready to print for your client.
BRUPHARM PHARMALAB
Summary
BRUPHARM PHARMALAB does better than half of its sector on 2 of the 13 ratios compared.
- Debt to equitybetter than 93%
- Days inventorybetter than 56%
- Current ratiobetter than 5%
- Quick ratiobetter than 5%
- Working-capital ratiobetter than 5%
Solvency and debt
Solvency is below 93% of 30,205 sector peers: in the least favourable quarter.
Position against the sector weakening since 2022.
Debt to equity is below 93% of 29,964 sector peers: in the most favourable quarter.
Position against the sector improving since 2022.
Interest coverage is below 91% of 26,293 sector peers: in the least favourable quarter.
Position against the sector stable since 2022.
Liquidity
The current ratio is below 95% of 29,924 sector peers: in the least favourable quarter.
Position against the sector stable since 2022.
The quick ratio is below 95% of 29,956 sector peers: in the least favourable quarter.
Position against the sector stable since 2022.
The working-capital ratio is below 95% of 30,139 sector peers: in the least favourable quarter.
Position against the sector stable since 2022.
Profitability
Return on equity is below 95% of 25,070 sector peers: in the least favourable quarter.
Return on assets is below 91% of 30,289 sector peers: in the least favourable quarter.
Position against the sector stable since 2022.
The net margin is below 95% of 4,050 sector peers: in the least favourable quarter.
Position against the sector stable since 2022.
The EBITDA margin is below 95% of 3,641 sector peers: in the least favourable quarter.
Position against the sector stable since 2022.
The gross margin is below 91% of 3,909 sector peers: in the least favourable quarter.
Position against the sector stable since 2022.
Working-capital cycle
Days sales outstanding is above 94% of 4,008 sector peers: in the least favourable quarter.
Position against the sector stable since 2022.
Days payable outstanding is above 90% of 4,030 sector peers.
Days inventory is below 56% of 3,384 sector peers: more favourable than the median.
Position against the sector stable since 2022.
Not computable
Long-term debt ratio. This company files the abbreviated or micro schema, in which turnover and purchases are optional; margins and credit terms therefore cannot be taken from its figures.
Source: filed annual accounts (NBB) and main activity (CBE register). Compared per fiscal year with each peer's latest statutory accounts; at least 30 peers per ratio. Prepared on 27 September 2026 via checked.be.